Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

April 13, 2023

Study Completion Date

September 1, 2024

Conditions
Tattoo; PigmentationCancer, Treatment-Related
Interventions
DEVICE

Semi-Permanent Tattoo Ink

Subjects will receive semi-permanent tattoo ink in place of the permanent ink utilized in the standard of care. Subjects will be monitored during their treatment course and for 15 months following treatment completion.

Trial Locations (1)

48202-2689

Henry Ford Health System, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ephemeral Solutions Inc.

INDUSTRY

lead

Henry Ford Health System

OTHER